Anuh Pharma is currently trading at Rs. 194.50, up by 4.60 points or 2.42% from its previous closing of Rs. 189.90 on the BSE.
The scrip opened at Rs. 194.45 and has touched a high and low of Rs. 195.30 and Rs. 186.00 respectively. So far 22586 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 5 has touched a 52 week high of Rs. 218.70 on 25-Aug-2020 and a 52 week low of Rs. 48.70 on 24-Mar-2020.
Last one week high and low of the scrip stood at Rs. 207.80 and Rs. 182.00 respectively. The current market cap of the company is Rs. 967.66 crore.
The promoters holding in the company stood at 72.09%, while Non-Institutions held 27.90% stake in the company.
Anuh Pharma has received approval from World Health Organization (WHO) - Geneva Prequalification for Pyrimcthamine API which is used as Anti - Malarial Durgs.
Anuh Pharma is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs) and a leading importer, exporter, distributor and manufacturer of bulk drugs, chemicals and pharmaceutical formulations.
